Russell Frank Boosts Share Size of Pfizer in Third Quarter

Wall St. Watchdog reveals information regarding Russell Frank Co’s top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 289 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $3.688 billion.

  • Pfizer Inc. (NYSE:PFE): On 06/30/2011, Russell Frank Co reported holding 25,899,769 shares with a market value of $533,535,251. This comprised 1.09% of the total portfolio. On 09/30/2011, Russell Frank Co reported holding 26,184,313 shares with a market value of $462,938,662. This comprised 1.19% of the total portfolio. The net change in shares for this position over the two quarters is 284,544. About Company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • Johnson & Johnson (NYSE:JNJ): On 06/30/2011, Russell Frank Co reported holding 3,948,230 shares with a market value of $262,636,246. This comprised 0.54% of the total portfolio. On 09/30/2011, Russell Frank Co reported holding 4,524,229 shares with a market value of $288,148,139. This comprised 0.74% of the total portfolio. The net change in shares for this position over the two quarters is 575,999. About Company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
  • Merck & Co. Inc. (NYSE:MRK): On 06/30/2011, Russell Frank Co reported holding 6,664,096 shares with a market value of $235,175,954. This comprised 0.48% of the total portfolio. On 09/30/2011, Russell Frank Co reported holding 5,979,645 shares with a market value of $195,534,396. This comprised 0.5% of the total portfolio. The net change in shares for this position over the two quarters is -684,451. About Company: Merck & Co., Inc. is a global pharmaceutical company that discovers, develops, manufactures, and markets a broad range of human and animal health products. Merck’s products include a treatment for elevated cholesterol, a treatment for male pattern hair loss, a preventive treatment for osteoporosis, a treatment for hypertension, and a treatment for allergic rhinitis.
  • Abbott Laboratories (NYSE:ABT): On 06/30/2011, Russell Frank Co reported holding 3,497,912 shares with a market value of $184,060,126. This comprised 0.38% of the total portfolio. On 09/30/2011, Russell Frank Co reported holding 3,467,278 shares with a market value of $177,316,595. This comprised 0.45% of the total portfolio. The net change in shares for this position over the two quarters is -30,634. About Company: Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company’s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
  • Thermo Fisher Scientific Inc. (NYSE:TMO): On 06/30/2011, Russell Frank Co reported holding 1,685,052 shares with a market value of $108,500,497. This comprised 0.22% of the total portfolio. On 09/30/2011, Russell Frank Co reported holding 3,088,503 shares with a market value of $156,401,790. This comprised 0.4% of the total portfolio. The net change in shares for this position over the two quarters is 1,403,451. About Company: Thermo Fisher Scientific, Inc. manufactures scientific instruments, consumables, and chemicals. The Company offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies.
  • Medtronic Inc. (NYSE:MDT): On 06/30/2011, Russell Frank Co reported holding 5,181,322 shares with a market value of $199,636,330. This comprised 0.41% of the total portfolio. On 09/30/2011, Russell Frank Co reported holding 4,364,076 shares with a market value of $145,061,894. This comprised 0.37% of the total portfolio. The net change in shares for this position over the two quarters is -817,246. About Company: Medtronic, Inc. develops therapeutic and diagnostic medical products. The Company’s principal products include those for bradycardia pacing, tachyarrhythmia management, atrial fibrillation management, heart failure management, heart valve replacement, malignant and non-malignant pain, and movement disorders. Medtronic’s products are sold worldwide.
  • Eli Lilly & Co. (NYSE:LLY): On 06/30/2011, Russell Frank Co reported holding 4,094,418 shares with a market value of $153,663,503. This comprised 0.32% of the total portfolio. On 09/30/2011, Russell Frank Co reported holding 3,748,101 shares with a market value of $138,567,299. This comprised 0.35% of the total portfolio. The net change in shares for this position over the two quarters is -346,317. About Company: Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The Company’s products are sold in countries around the world. Eli Lilly’s products include neuroscience products, endocrine products, anti-infectives, cardiovascular agents, oncology products, and animal health products.
  • Gilead Sciences Inc. (NASDAQ:GILD): On 06/30/2011, Russell Frank Co reported holding 2,805,682 shares with a market value of $116,183,291. This comprised 0.24% of the total portfolio. On 09/30/2011, Russell Frank Co reported holding 3,109,870 shares with a market value of $120,662,954. This comprised 0.31% of the total portfolio. The net change in shares for this position over the two quarters is 304,188. About Company: Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company’s primary arees of focus include HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions.
  • Baxter International Inc. (NYSE:BAX): On 06/30/2011, Russell Frank Co reported holding 1,995,034 shares with a market value of $119,083,577. This comprised 0.24% of the total portfolio. On 09/30/2011, Russell Frank Co reported holding 1,991,601 shares with a market value of $111,808,479. This comprised 0.29% of the total portfolio. The net change in shares for this position over the two quarters is -3,433. About Company: Baxter International Inc. develops, manufactures, and markets products and technologies related to hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. The Company’s products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices, and research laboratories.
  • Teva Pharmaceutical Industries Limited (NASDAQ:TEVA): On 06/30/2011, Russell Frank Co reported holding 2,362,572 shares with a market value of $113,923,225. This comprised 0.23% of the total portfolio. On 09/30/2011, Russell Frank Co reported holding 2,935,518 shares with a market value of $109,259,984. This comprised 0.28% of the total portfolio. The net change in shares for this position over the two quarters is 572,946. About Company: Teva Pharmaceutical Industries Ltd. develops, manufactures and markets generic and branded human pharmaceuticals and active pharmaceutical ingredients. The Company produces antibiotics, oncological products, Alpha D3 for treatment of post-menopausal bone loss in women and Copaxone for treatment of multiple sclerosis. Teva develops novel drugs for diseases of the central nervous system.

(Note: Data regarding Russell Frank Co’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>